Enteric coated mycophenolate sodium

DRUG2 trials

Sponsors

University of Pennsylvania, Bristol-Myers Squibb

Conditions

Renal Allograft RecipientsTransplants and Implants

Phase 3

A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

RecruitingNCT04877288

Bristol-Myers SquibbRenal Allograft Recipients

Start: 2021-07-21End: 2034-06-30Target: 102Updated: 2026-08-31

Phase 4

Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

TerminatedNCT00522548

University of PennsylvaniaTransplants and Implants

Start: 2007-03-31End: 2011-01-31Updated: 2018-01-23